References
- Atawodi SE, Bulus T, Ibrahim S, Ameh DA, Nok AJ, Mamman M, Galadima M (2003): In vitro trypanocidal effect of methanolic extract of some Nigerian savannah plants. Afr J Biotechnol 2: 317–321.
- Barnes J, Anderson LA, Gibbons S, Phillipson JD (2005): Echinacea species (Echinacea angustifolia (DC.) Hell. Echinacea pallida (Nutt.) Nutt. Echinacea purpurea (L.) Moench.: A review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 57: 929–954.
- Barrett B (2003): Medicinal properties of Echinacea: A critical review. Phytomedicine 10: 66–86.
- Bauer R (1998): Echinacea: Biological effects and active principals. Phytomedicines of Europe: Chemistry and biological activity, in: Lawson LD, Bauer R, eds, ACS symposium series 691. Washington DC, American Chemical Society, pp. 140–157.
- Binns SE, Livesey JF, Arnason JT, Baum BR (2002): Phytochemical variation in Echinacea from roots and flower heads of wild and cultivated populations. J Agric Food Chem 50: 3673–3687.
- Braga FG, Bouzada MLM, Fabri RL, Matos MO, Moreira FO, Scio E, Coimbra ES (2007): Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. J Ethnopharmacol 111: 396–402.
- Desrivot J, Waikedre J, Cabalion P, Herrenknecht C, Bories C, Hocquemiller R, Fournet A (2007): Antiparasitic activity of some New Caledonian medicinal plants. J Ethnopharmacol 112: 7–12.
- Gamboa-Leon MR, Aranda-Gonzalex I, Mut-Martin M, Garcia MR, Dumonteil E (2007): In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production. Scand J Immunol 66: 508–514.
- Hay A-E, Merza J, Landreau A, Litaudon M, Pagniez F, Pape PL, Richomme P (2008): Antileishmanial polyphenols from Garcinia vieillardii. Fitoterapia 79: 42–46.
- Matthias A, Banbury L, Bone KM, Leach DN, Lehmann RP (2008): Echinacea alkylamides modulate induced immune responses in T-cells. Fitoterapia 79: 53–58.
- Sharma M, Arnason JT, Burt A, Hudson JB (2006): Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Phytother Res 20: 147–152.
- Sharma M, Schoop R, Hudson JB (2008): Echinacea as an antiinflammatory agent: The influence of physiologically relevant parameters. Phytotherapy Res 23: 863–867.
- Sharma M, Anderson S, Schoop R, Hudson JB (2009): Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res 83: 165–170.
- Vimalanathan S, Kang L, Treyvaud Amiguet V, Livesey J, Arnason JT, Hudson J (2005): Echinacea purpurea aerial parts contain multiple antiviral compounds. Pharm Biol 43: 740–745.
- Vimalanathan S, Arnason JT, Hudson JB (2009): Anti-inflammatory activities of Echinacea extracts do not correlate with traditional marker components. Pharm Biol 47: 430–435.
- Vohra S, Adams D, Hudson JB, Moore JA, Vimalanathan S, Sharma M, Burt AJ, Lamont E, Lacaze N, Arnason JT, Lee TDG (2009): Selection of natural health products for clinical trials: A preclinical template. Can J Physiol Pharmacol 87: 371–378.
- WHO (World Health Organization) (2008a): Leishmaniasis. Available At http://www.who.int/leishmaniasis/disease_epidemiology/en/index.html (accessed April 28, 2008).
- WHO (World Health Organization) (2008b) African trypanosomiasis (sleeping sickness). Available at http://www.who.int/mediacentre/factsheets/fs259/en/ (accessed April 28, 2008).